FGF23 and chronic kidney disease: The Homocysteine Study Cognitive Function Substudy, which included 600 participants with advanced CKD as well as participants requiring maintenance hemodialysis, found no cross-sectional association between c-terminal FGF-23 and cognitive impairment, though the cognitive outcome was based on a single telephone based cognitive test [8].